Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | TRK-950 |
| Trade Name | |
| Synonyms | TRK 950|TRK950 |
| Drug Descriptions |
TRK-950 is a monoclonal antibody that targets Caprin-1, potentially leading to antitumor activity (PMID: 40557916). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C142826 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Carboplatin + Gemcitabine + TRK-950 | Carboplatin Gemcitabine TRK-950 | 0 | 1 |
| Cisplatin + Gemcitabine + TRK-950 | Cisplatin Gemcitabine TRK-950 | 0 | 1 |
| Fluorouracil + Irinotecan + Leucovorin + TRK-950 | Fluorouracil Irinotecan Leucovorin TRK-950 | 0 | 1 |
| Gemcitabine + TRK-950 | Gemcitabine TRK-950 | 0 | 0 |
| Imiquimod + TRK-950 | Imiquimod TRK-950 | 0 | 1 |
| Nivolumab + TRK-950 | Nivolumab TRK-950 | 0 | 1 |
| Paclitaxel + Ramucirumab + TRK-950 | Paclitaxel Ramucirumab TRK-950 | 0 | 2 |
| Pembrolizumab + TRK-950 | Pembrolizumab TRK-950 | 0 | 1 |
| TRK-950 | TRK-950 | 0 | 1 |